I checked again Tuspetinib on Clinicaltrials.gov. It says "Venetoclax will be given to patients in combo treatment group (Part C) either in 50 mg or 100 mg tablets". Not sure whether they are distinct doses or just dose increments. https://clinicaltrials.gov/ct2/show/NCT03850574?term=aptose&draw=2&rank=4